Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.
about
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survivalCyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heartAngiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signalingRole of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin ResistanceThe PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts.Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene.Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytesThe impact of age-related dysregulation of the angiotensin system on mitochondrial redox balanceDecreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen speciesSynergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells.Cyclic nucleotide phosphodiesterase 1 and vascular agingInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].The effects of pravastatin on the normal human placenta: Lessons from ex-vivo modelsRole of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusionAssociation of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function.Nitric oxide reduces Cl⁻ absorption in the mouse cortical collecting duct through an ENaC-dependent mechanism.Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension.Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptorsEndothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migrationAngiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway.Local renin-angiotensin systems in the genitourinary tract.Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.Salt, Angiotensin II, Superoxide, and Endothelial Function.AT1 receptor signaling pathways in the cardiovascular system.Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.Nitric oxide regulates pulmonary vascular smooth muscle cell expression of the inducible cAMP early repressor geneDifferential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels.Role of some vasoactive mediators in patients with erectile dysfunction: their relationship with angiotensin-converting enzyme and growth hormone.Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice.Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.Glyceryl trinitrate-induced angiotensin-converting enzyme (ACE) inhibition in healthy volunteers is dependent on ACE genotype.Cross talk between kinin and angiotensin II receptors in mouse abdominal aorta.An update on vinpocetine: New discoveries and clinical implications.The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells.
P2860
Q27339740-D52AD5F8-E10D-47F7-8B6C-61CC5FEC0F19Q28568576-1A064E1C-6C5C-4471-8F61-336C5E4B56B5Q28574432-FA4485FC-8628-471C-B7B6-1A668133A4CDQ28575995-08D60406-A618-40FC-BB0F-7EBB7DB97325Q30234634-82F80A36-093B-41CC-A809-07D445D87EA2Q33792164-A81F98E1-C829-42B9-9C5A-F0049F4B84BFQ33966155-839DE780-DDA7-402A-86B2-59CC66768431Q34252901-31CBCB21-3CA5-44E5-8037-797DDF379316Q34426146-E864E7F9-82AD-4339-9EE7-4C15B52F6F92Q34541263-75983B9E-690C-4307-8A37-35874DEFB4F0Q34562975-E884BE24-0811-4A4D-BFAC-71383650A61BQ34780141-5B1BEFC9-C80E-4DA5-BD98-468EFCC67BFFQ35037357-25892C9C-DF16-4A38-84CD-61E21E138587Q35562287-3639DC95-07CF-43A9-A957-E62EDA5D12A3Q36175455-0D0DC2E1-AB2A-47C4-AA66-B53F1AF85D1FQ36241932-AD3D3727-4B32-4CBB-BA4F-BED2DE7A2053Q36281300-536FD6E6-811E-49E5-873E-4200A6FEBB49Q36603913-2F66C78E-35CF-40A4-A759-AF77A3B7F207Q36647441-85021919-F42A-423B-8A9C-CF83A9EBD5E3Q36923671-20E429F0-87A1-434F-A48F-9D2D82199958Q37107449-52736EBC-C900-4731-A65D-4C4086856860Q37167494-68BC72B6-5586-44A0-90E4-3D2069B6DD4DQ37248451-245C9DE4-BC88-4B32-B036-DD2D5ED37E63Q37337903-41FF5DC4-C984-4A0E-985D-018AD98D7B90Q37955678-5C9810EA-0BEC-4355-9A23-61AEE2603BE0Q38130262-BDEB8189-EB73-47A6-8833-0AC434B90EB0Q38693277-710593BD-89E5-45E4-A9C5-40AD1B2D8926Q39319793-F53A9E4C-D6D2-427B-9824-CD9CFD616CDAQ41195003-A5FFA93E-377E-40E3-B180-1AB8051711F5Q42463492-3A495D78-53CA-4929-B72F-1D2AEE0098C6Q44542218-7BBA325F-85DA-4AB6-AEDA-E4C0341C4F54Q44690668-C6319C4C-EF4A-448E-B565-AFC9EBEFA88BQ45937864-9E4B421C-3A60-4383-B49D-8568F58C5F02Q46020956-45BFA936-870D-4B94-A498-3AE064D517FEQ46876455-D2725190-42F9-459A-8AE0-C7711780FFC0Q46931504-676967CB-1BEE-4A73-AD12-86CAC59C53E7Q47770306-8C839273-7B15-40BE-AC24-2878745121C2Q49567493-C64BC365-8BA1-4953-B03C-012BD540E373Q49804487-D75613A4-6F0D-4DF7-95F4-57801BEC68D4Q50721327-C461E156-C835-4AEF-A883-DD032237C02A
P2860
Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Functional interplay between a ...... cyclic GMP as a key mediator.
@en
type
label
Functional interplay between a ...... cyclic GMP as a key mediator.
@en
prefLabel
Functional interplay between a ...... cyclic GMP as a key mediator.
@en
P2093
P1476
Functional interplay between a ...... cyclic GMP as a key mediator.
@en
P2093
Bradford C Berk
Dongsoo Kim
Toru Aizawa
P356
10.1161/01.ATV.0000046231.17365.9D
P407
P577
2003-01-01T00:00:00Z